Capitainer Makes
Self-Sampling
Easy and Accurate
Simple
Designed for self sampling.
High success rate for first time users
Accurate
Delivers similar volumetric precision & accuracy to traditional pipetting.
Trusted
Next generation of dried blood spots, the established standard for blood sampling.
Our Mission
We are improving healthcare outcomes for all by providing universally applicable precision sampling technologies.
COVID-19
COVID-19 Antibody Testing: We Believe Home Sampling Is Key
We believe Home Sampling has a key role to play in helping health authorities and healthcare providers meet the challenges of this unprecedented crisis. Large-scale antibody testing is required to generate essential epidemiological data for better risk management and to enable more targeted and effective government intervention. Learn more about how the Capitainer qDBS device is helping. Learn more
Instructions For Use
Using Capitainer Is Simple
Capitainer qDBS device is intended to be used for self sampling. Where required, it can also be used for assisted sampling.
View our video to see for yourself how easy and convenient sampling is with the Capitainer qDBS device or visit our Use page via the button below.
Microfluidsystem Based Technology
Near-Patient Blood Sampling – At a location of your choice.
Patients can collect high quality blood samples themselves in a location that is convenient to them. The samples are then sent to the laboratory for analysis through the regular mail. This is enabled by Capitainer´s new disposable sampling chip that automatically meters and stores an exact blood volume.
Keep Updated
Our Latest News
Read how Sweden’s Västerbotten Region is introducing home sampling for COVID-19 antibodies together with Capitainer.
Launch of Capitainer® B Vanadate, a blood sampling card that eliminates the risk of inaccurate test results when analyzing PEth.
Capitainer Wins Swedish Guldpillret for its qDBS self-sampling device
Home sampled blood with Capitainer successfully used for multianalyte serology with the Luminex platform
qDBS dried blood spot system proves 97% effective for clinical mass-testing of Covid-19 vaccine efficacy